| pubmed-article:21220347 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1417123 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C0549473 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C0205312 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1516516 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C0037083 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C0025646 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1425650 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1517773 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1546857 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1556066 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1619636 | lld:lifeskim |
| pubmed-article:21220347 | lifeskim:mentions | umls-concept:C1514873 | lld:lifeskim |
| pubmed-article:21220347 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21220347 | pubmed:dateCreated | 2011-1-26 | lld:pubmed |
| pubmed-article:21220347 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:abstractText | The receptor tyrosine kinase MET is frequently amplified in human tumors, resulting in high cell surface densities and constitutive activation even in the absence of growth factor stimulation by its endogenous ligand, hepatocyte growth factor (HGF). We sought to identify mechanisms of signaling crosstalk that promote MET activation by searching for kinases that are coordinately dysregulated with wild-type MET in human tumors. Our bioinformatic analysis identified leucine-rich repeat kinase-2 (LRRK2), which is amplified and overexpressed in papillary renal and thyroid carcinomas. Down-regulation of LRRK2 in cultured tumor cells compromises MET activation and selectively reduces downstream MET signaling to mTOR and STAT3. Loss of these critical mitogenic pathways induces cell cycle arrest and cell death due to loss of ATP production, indicating that MET and LRRK2 cooperate to promote efficient tumor cell growth and survival in these cancers. | lld:pubmed |
| pubmed-article:21220347 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21220347 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21220347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21220347 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21220347 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:21220347 | pubmed:issn | 1091-6490 | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:ResauJames... | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:FurgeKyle AKA | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:GiordanoThoma... | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:MacKeiganJeff... | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:TehBin TBT | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:WestAndrew... | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:SwiatekPamela... | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:LooyengaBrend... | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:DykemaKarl... | lld:pubmed |
| pubmed-article:21220347 | pubmed:author | pubmed-author:KoemanJulieJ | lld:pubmed |
| pubmed-article:21220347 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21220347 | pubmed:day | 25 | lld:pubmed |
| pubmed-article:21220347 | pubmed:volume | 108 | lld:pubmed |
| pubmed-article:21220347 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21220347 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21220347 | pubmed:pagination | 1439-44 | lld:pubmed |
| pubmed-article:21220347 | pubmed:dateRevised | 2011-8-1 | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
| pubmed-article:21220347 | pubmed:meshHeading | pubmed-meshheading:21220347... | lld:pubmed |
